Abstract. The glycosaminoglycan chains of cell surface heparan sulfate proteoglycans are believed to regulate cell adhesion, proliferation, and extracellular matrix assembly, through their interactions with heparin-binding proteins (for review see Ruoslahti, E. 1988. Annu. Rev. Cell Biol. 4:229-255; and Bernfield, M., R. Kokenyesi, M. Kato, M. T. Hinkes, J. Spring, R. L. Gallo, and E. J. Lose. 1992. Annu. Rev. Cell Biol. 8:365-393). Heparin-binding sites on many extracellular matrix proteins have been described; however, the beparin-binding site on type I collagen, a ubiquitous heparin-binding protein of the extracellular matrix, remains undescribed. Here we used heparin, a structural and functional analogue of heparan sulfate, as a probe to study the nature of the heparan sulfate proteoglycan-binding site on type I collagen. We used affinity coelectrophoresis to study the binding of hepatin to various forms of type I collagen, and electron microscopy to visualize the site(s) of interaction of heparin with type I collagen monomers and fibrils. Using affinity coelectrophoresis it was found that heparin has similar affinities for both procollagen and collagen fibrils (Kd'S ~,60-80 nM), suggesting that functionally similar heparin-binding sites exist in type I collagen independent of its aggregation state. Complexes of heparin-albumin-gold particles and procoLlagen were visualized by rotary shadowing and electron microscopy, and a preferred site of heparin binding was observed near the NH2 terminus of procollagen. Native or reconstituted type I collagen fibrils showed one region of significant heparin-gold binding within each 67-nm period, present near the division between the overlap and gap zones, within the "a" bands region. According to an accepted model of collagen fibril structure, our data are consistent with the presence of a single preferred heparin-binding site near the NH2 terminus of the collagen monomer. Correlating these data with known type I collagen sequences, we suggest that the heparin-binding site in type I collagen may consist of a highly basic triple helical domain, including several amino acids known sometimes to function as disaccharide acceptor sites. We propose that the heparin-binding site of type I collagen may play a key role in cell adhesion and migration within connective tissues, or in the cell-directed assembly or restructuring of the collagenous extracellular matrix.
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I
NTERACTIONS between heparan sulfate proteoglycans CHSPGs) ~ and collagen fibrils are thought to play important roles in cell adhesion (Koda et al., 1985; Piepkorn and Chapman, 1985) , and in the formation of extracellular matrix structures such as basement membranes (Tsllibary et al., 1988 (Tsllibary et al., , 1990 Koliakos et al., 1989) . It has been shown that HSPGs, heparan sulfates, and heparin each bind to type I collagen fibrils (Stamataglou and Keller, 1982; Keda et al., 1985; Keller et al., 1986; LeBaron et al., 1989) .
The high affinity interaction between HSPGs or heparin and type I collagen fibrils is not common to other glycosaminoglycans (Koda et al., 1985; LeBaron et al., 1989) . Furthermore, the interaction is completely disrupted by high salt, suggesting a primarily electrostatic basis for the binding (Koda et al., 1985; Keller et al., 1986) . It has also been demonstrated that the native character of the collagen triple helix is required for high affinity HSPG/heparin-type I collagen binding (Koda et al., 1985; Keller et al., 1986; San Antonio et al., 1992) , and that the COOH-terminal triple helical fragment of type I collagen, as generated by vertebrate collagenase treatment, shows an apparently higher affinity for heparin than does the NH2-tenninal triple helical fragment (Keller et al., 1986) . Aside from a requirement for triple helical structure, the features of the type I collagen fibril necessary for HSPG or heparin binding remain unknown. Thus, here we attempted to define the HSPG-binding sites on type I collagen, owing to the likely importance of these sites in the interactions between cell surfaces and type I collagen-one of the most abundant molecules of the extracellular matrix. Thus, in this manuscript we have characterized heparin-colhgen interactions by affinity coelectrophoresis (ACE) and, using electron microscopy, sites of interaction were mapped for the binding of heparin-colloidal gold complexes to individual type I procollagen molecules and to both native and reconstituted type I collagen fibrils.
Materials and Methods

Collagen Preparations
Procollagen ~ I. Procollagen type I was isolated as detailed (Olsen et al., 1976) . Briefly, leg tendons were dissected from 17-d-old chick embryos, digested with trypsin and collagenase, and then the tendon fibroblasts were pelleted. Tendons from twelve dozen embryos yielded about 2 x 109 cells, which were placed in suspension culture for 6 h. Procollagen type I was isolated from the culture medium of the suspension cultures by ammonium sulfate precipitation with final protein yields of •1.5 mg observed. Procollagen type I purity was confirmed by SDS-PAGE analysis, and protein concentration was determined by amino acid analysis, performed by the Biopolymer Laboratory of the Brigham and Women's Hospital (Boston, MA).
Collagen ~ype I
Acid Soluble. Collagen from rat tail tendons was isolated as described (San Antonio et al., 1992) . Briefly, tendons were subjected to three cycles of extraction/precipitation with 0.5 N acetic acid/7.5% NaCI, and purity was confirmed by SDS-PAGE.
Native. Tendons were removed from the tails of 5-10 Long Evans rats and were placed in 0.1 M Tris HC1, 0.1 M NaC1, pH 7.5, with 1 mM PMSF and I mM EDTA. All procedures were conducted at 40C, and used the same buffer as detailed above. Tendons were rinsed several times in buffer, and were diced into pieces of ,,ol cm using a razor blade and scissors. The sampie was suspended in 100 ml of buffer, and homogenized at high speed in a food processor. The collagen was pelleted at 1,000 g/10 min, and the supernatant discarded. The pellet was resuspended in 100 rrd of buffer, and was homogenized for 5 rain. Insoluble collagen was pelleted at 10,000 g/lO rain, the pellet was discarded, and the supematant passed through a thick layer of cotton gauze. The collagen was pelleted at 15,000 g/20 min, resuspended in 10 ml of buffer, then pelleted again at 15,000 g/20 min. The pellet was placed in <1 ml of buffer, dispersed by a brief sonication on ice, and samples were used in electron microscopy studies. Some samples were further treated with chondroitinase ABC. Fibril suspensions were diluted 1:5 in enzyme buffer, and were incubateA with 0.05 U/ml cbondroitinase ABC (Sigma Chem. Co., St. Louis, MO) for 3 h at 37°C (Koda and Bernfield, 1984) . Afterwards, fibril samples were pelleted and rinsed 2x in homogenization buffer, and then used in electron microscopy studies.
Heparin
Heparin (grade I, porcine intestinal mucosa) was from Sigma Chem. Co. Heparin was substituted with tyramine at the polysaccharide's reducing end (San Antonio et al., 1993) , radioiodinated to a specific activity of about 30,000 cpm/ng, and then radioiodinated low Mr 125I-Tyramine-labeled heparin chains (z25I-Tyr-heparin) of Mr <6,000 were isolated by Sephadex G-100 chromatography (Laurent et al., 1978; Jordan et al., 1979; Rosenberg et al., 1979) . Heparin-BSA-gold colloid (5-rim particles) was from Sigma Chem. Co., and BSA-gold colloid (5-aM particles) was from E. M. Sciences (Fort Vchshington, PA). All other reagents used for ACE experiments were as described (Lee and Lander, 1991) .
ACE
Procolingen 7),pc I. Procollagen samples were stored at 0.5-1.0 mg/ml in 0.05 M ammonium acetate/ammonium bicarbonate, pH 7.8, and were prepared for ACE as detailed for other soluble proteins (Lee and Lander, 1991) .
Acid Soluble ~e 1 Collagen. Acid soluble lyophilized collagen samples were dissolved in 0.5 N acetic acid at 2.4 mg/mi, with gentle stirring overnight at 4"C. Collagen was serially diluted in 0.5 N acetic acid. Samples were rapidly neutralized by the addition of an equal volume of 0.5 N NaOH, mixed with warm 2x concentrated electrophoresis running buffer and agarose, and then poured into agarose wells (San Antonio et al., 1992) . Electrophoresis of 1251-Tyr-heparin through agarose wells each containing one in a series of concentrations of protein was performed as described (Lee and Lander, 1991) .
Reconstituted b'IbrUlar ~ I Collagen. Lyophilized collagen samples were dissolved in 0.5 N acetic acid at 1.2 mg/ml, with gentle stirring overnight at 4°C. Collagen was then dialyzed against 0.02 M Na2HPO4 for 48 h at 4°C. After dialysis the collagen formed a fibrous white precipitate. The sample was then sonicated with a steel probe sonicator (Braunosonic 1510; B. Braun Biotech haft., Melsungen, Germany) on ice with five pulses, with each lasting ~5 s, and with each spaced ,~15 s apart from the next pulse to avoid warming and melting the collagen. After this treatment the sample formed a visually homogenous milky white suspension. The collagen was serially diluted into the same phosphate buffer. Samples were mixed with an equal volume of 2x ACE gel buffer salts, and then with an equal volume of 2× agarose, and poured into agarose wells. Electrophoresis of heparin through these gels was as described above.
Preparation of Samples for Electron Microscopy of
ProcoUagen-Heparin-Gold Complexes
Procollagen was dialyzed into 0.2 M potassium borate buffer (pH 8.0). BSA-heparin-gold 5-nm colloid was centrifuged 30 rain at 60,000 g and the pellet resuspended in a small volume of buffer. The procollagen and hepafin-gold were mixed (25 ttg of procollagen plus 0.25 mi of concentrated 5-um heparin-gold), allowed to bind for 15 rain at 25°C, and loaded into a Sepharose 4B column of 6.9-ml bed volume poured and equilibrated in 0.2 M (NH4)2 CO3 (pH 8.25). In some cases the reaction mixture was fixed with glntaraldehyde before loading on the column. The column was ehited at '~5 ml/h and fractions of 0.2 mi were collected and analyzed by electrophoresis for protein, and by measuring As20 to monitor heparin-gold content. Generally the first three fractions after the void volume were used for electron microscopy. Samples were prepared for electron microscopy as described by Margossian et al. (1991) .
Electron Microscopy of ProcoUagen
Approximately 20-#g/ml solutions of complex were mixed with 0.25 vol of glycerol, sprayed on to freshly cleaved mica, dried in vacuo for 20 h, and rotary shadowed with platinum or tungsten by means of resistive or electron bombardment heating, respectively (Slayter, 1976 (Slayter, , 1983 . The estimated average metal-film mass thickness was 100 ng/cm 2 for tungsten and somewhat more for platinum. Samples were examined in the JEM 100CX electron microscope, using a top entry stage voltage with a 40-/zm objective aperture, and at 100 kV acceleration voltage. Most micrographs were recorded at a magnification of 20,000x and enlarged photographically to 50,000 or 100,000 ×. High resolution darkfield images were also obtained, from the lightly shadowed specimens, by using matched annular condenser and objective apertures (Slayter, 1989 (Slayter, , 1991 .
Electron Microscopy of Fibrous Collagen
Reconstituted and native type I collagen fibrils were prepared as detailed above. Specimens of fibrous collagen were deposited on carbon-filmed grids, incubated at 4"C with heparin-gold for 30 rain, washed with 0.1 M cacodylate buffer, pH 7.4, fixed 5 min with 0.25% glutaraldehyde in 0.1 M cacodylate buffer at pH 7.0, washed 3 × with water, and then stained with 1% uranyl acetate without thorough poststain washing (Slayter, 1983) . Calibration was based on micrographs of grating-replica standards and of Indanthrene Olive crystals (Labaw, 1964) .
Electron Microscopy of Frozen Sections
Blocks of rat tail tendon (0.5 ram) were fixed for 1 h in 0.1% glutaraldehyde in Stefanini (1967) fixative (4% paraformaldebyde, 15% saturated in neutralized picric acid). Tissue blocks were then immersed overnight at 40C in PBS containing 2.3 M sucrose. These were maintained in a liquid nitrogen refrigerator until use, for a minimum of 24 h. Specimen blocks mounted on cutting stubs were removed and sections were obtained with thickness "~60 nm. The methods used are essentially those of Tokoyasu and coworkers (Tokoyasu and Singer, 1976; Tokoyasu et al., 1983) as modified by Watkins et al. (1990) . Thin sections were cut with a Reichert Ultracut Ultramicrotome fitted with an FC4D cryochamber (Vienna, Austria) at a temperature range of -110 to -130"C. The sections were mounted on Formvar/carboncoated 200-mesh inch -1 grids and labeled as previously described (Geuze et al., 1981) . Sections were labeled by 30-min incubations with heparingold at '~60/~g/ml, washed, counterstained with uranyl acetate, and embedded in 1.25% methylcellulose as previously described (Watkins et al., 1991) . Sections were examined with a JEOL 100CX electron microscope at 20,000x using a 40-tan objective aperture (JEOL U.S.A. Inc., Peabody, MA).
Results
Binding of Heparin to Different Forms of 1)ppe I Collagen
The binding interaction of heparin with monomeric and fibrillar collagen was studied using ACE. Type I collagen was incorporated into ACE gels in the following forms: procollagen type I (collagen monomers); reconstituted, acidsolubilized type I collagen, and reconstituted, fibrillar type I collagen. Electrophoresis of 125I-Tyr-heparin was conducted through the collagen-containing lanes of ACE gels and electrophoretograms are shown in Fig. 1 a. Retardation coefficients (R) of the heparin migration fronts within each ACE gel lane were measured, and are plotted versus protein concentration (Fig. I b) . From these curves the apparent average Kd'S of the binding between heparin and the collagen preparations were derived. In two experiments, apparent Kd's (in nM) for heparin binding were: procollagen, 58 5-2; acid soluble collagen, 79 + 16; fibrillar collagen, 79 5-14. These data indicate that the apparent affinities exhibited by each of the collagen preparations for heparin are not significantly different from each other. Furthermore, these affinities are in the range of those exhibited by other heparinbinding proteins for heparin (Lee and Lander, 1991; San Antonio et al., 1993) .
Figure 1. (a) ACE analysis of the interactions between low Mr 1251-
Tyr-heparin and various forms of type I collagen. ACE gels were constructed containing type I collagen in the procollagen, acid solubilized, or reconstituted, fibrillar form. Collagens were present in gel lanes at the concentration (nM) indicated beneath each lane, with Mr's taken to be 450 K for procollagen, and 300 K for the other forms. Radiolabeled heparin was loaded into a sample slot (located above each gel), and electrophoresis was conducted towards the anode 0ocated below each gel). Images of heparin migration patterns within ACE gels were obtained using a phosphorimager (Molecular Dynamics). From these electrophoretograms, the dissociation constant (Kd) Can be estimated from the protein concentration at which the heparin is half-shifted from being fully mobile at very low protein concentrations or between protein-containing lanes, to being maximally retarded at high protein concentrations (Lee and Lander, 1991) . ( 
Visualization of Heparin-binding Sites on ~ I Collagen Monomers and ~brils
Mapping of Procollagen. To map the heparin-binding site on collagen monomers, electron microscopy was used to examine complexes between heparin-gold reagent and procollagen in solution. Rotary-shadowed preparations were made of the material obtained from the excluded volume of the gel filtration step used to separate unbound heparin-gold from that which is complexed with the procoUagen (Fig. 2) . We obtained micrographs of the complex material mixed with unbound procoUagen. In the course of these experiments it was discovered that the fraction excluded at the column-void volume (fraction 17) contained a large proportion of large intermolecularly cross-linked collagen complexes associated with some heparin-gold, but that individual procollagen complexes with heparin-gold reagent were rare. On the other hand, fraction 22 contained a much greater proportion of monomolecular complexes. Complexes representative of the variety encountered are shown in Fig. 3 , including some containing more than one procollagen molecule. Procollagen is shown in Fig. 3 (upper left) with the characteristic 10-rim head. In the first five rows of selected micrographs of complexes of a single procollagen molecule with hepafin-gold, the position of binding is clearly identified by the characteristic gold colloid particle with a dense core. In rows 6-9, complexes are illustrated in which procollagens are bound together by a single multivalent heparin-gold colloid particle. The positions of the heparin-gold particles on procollagen molecules were measured for complexes obtained under different experimental conditions. Fig. 4 summafizes the location of hepafin-gold particles in several representative experiments as a function of their position relative to the center of the COOH-terminal head of procollagen. The histograms show a principal peak of heparin binding near the NH~ terminus of procollagen. Quantitative results are summarized in Table I .
To stabilize complexes, we subjected them to glutaraldehyde fixation, using a series of glutaraldehyde concentrations, buffered to neutrality. The fixation reaction was stopped by adding an excess of glycine to block unbound glutaraldehyde, thus minimizing both intramolecular crosslinking between procollagen molecules and background due to possible nonspecific cross-linking between the hepafin-gold and procollagen. Preferred regions of heparin-gold .01 --290 maj * Distance in ran from COOH terminus, or center of head, in procollagen, to center of heparin-gold marker. GA, glutaraldehyde; maj, major peak; rain, minor peak (collagen = 328 nm in same experiment).
binding were found in all of the experiments (Fig. 4) , and the data are summarized in Table I . Most of the heparin-gold is found at a site very near the tail end of the molecule. The peak at •10-20 nm from the head, is somewhat suppressed at the higher glutaraldehyde concentrations (Fig. 4, a and b) , but the other peak *290 nm from the head (very near the tall end), is always maintained (Fig. 4) . Validity of these results was supported by a control experiment in which bovine serum albumin complexed with gold was used in mapping experiments and failed to bind to procollagen (data not shown).
Mapping of Reconstituted Collagen Fibrils. Our finding
of one preferred heparin-binding site on procollagen monomers led us to determine if hepafin-binding sites are also available in the type I collagen fibril, which is a structure composed of overlapping collagen monomers. Thus, mapping experiments were undertaken with several forms of fibrous collagen. Labeled fibrils were selected and scored for the position of the heparin-gold particles in relation to the 67-nm repeat of native-type fibrils, measuring from the beginning of the overlap zone (Fig. 5 c, arrow) toward the gap zone. Fig. 5 c shows a typical type I collagen fibril heavily labeled with heparin-gold in the region of the "a" bands. The data were plotted as histograms and are shown in Fig. 6 . A single major peak is clearly evident in Fig. 6 a at a position ,,o35 nm from the origin, with a possible minor peak at 65 nm. No other significant hot spot is seen in this profile. The experiment was repeated several times and, always, major peaks at "°30--35 nm were found as indicated in Table II .
Mapping of Native Collagen Fibrils. We next tested
whether the beparin-binding sites we observed in reconstituted collagen fibrils might be available for heparin binding in native fibrils in vivo, by examining heparin-gold binding by native collagen not only in preparations of homogenized rat tall tendon, but also in frozen sections of rat tall. Isolated native fibrils from homogenized tendon, and frozen sections of unfixed rat tendon when stained with heparin-gold, showed a major peak at "-30 nm from the head and a minor peak at ,,o62 nm from the head (Fig. 6, b and c) . Table II summarizes the results of a number of different experiments. A control experiment was performed in which the access of heparingold was blocked by the presence of heparin (•200 #g/ml). Under these conditions the major peak of heparin-gold binding at the center of the molecule virtually disappeared. (Gross and Schmitt, 1948) . Dotted lines between molecular model in b and the electron micrograph show corresponding overlap and gap zones. The location of heparin-gold particles relative to the molecular structure of the fibril as presented in Fig. 6 was measured within each 67-nm period, beginning at the center of the left border of the overlap zone (origin, arrow), and extending to the center of the right border of the gap zone. Heparin-gold particles appear as circular dark objects present mainly in the "a" bands region of the fibrils.
gen Fibrils. In another series of experiments the heparin-gold-binding site of native rat tail type I collagen was mapped before and after treatment of the collagen fibrils with chondroitinase. It was thought that chondroitinase treatment might uncover sites on collagen fibrils that are masked by endogenous proteoglycans such as decorin, thus making mapping of heparin-binding sites more definitive. In two experiments, the primary binding site was ,'~30 nm from the head. A second minor site at •65 nm became somewhat more discrete after the chondroitinase treatment, but overall, chondroitinase treatment of fibrils had little effect on heparin-gold binding to fibrils. Table II shows histograms summarizing the data from these experiments. Since segment long spacing preparations of type I collagen are formed at low pH in acetic acid, and heparin-gold is unstable under these conditions, mapping experiments were found not possible to conduct on segment long spacing fibrils.
For the mapping experiments, the potential error in assigning positions on the basis of the heparin-gold label procedure is dependent upon several factors. First, the albuminheparin-gold complex is '~10 nm in diameter. (The complex is visualized to be 10 nm in the metal-coated molecular preparations but only the 5-nm gold core is visualized in the fibrillar preparations.) Second, this marker could attach from the left, right, above, or below relative to the actual binding site. Third, some shrinkage upon dehydration (up to 10%) may be expected in procollagen. Finally, markers may detach slightly prior to or during fixation. However, the data show a number of rather narrow (10 nm, two histogram bars) histogram maxima peaks. It is thus concluded that all factors mentioned other than the marker size must be of lesser importance and suggest that the error is roughly the size of the marker.
Discussion
Here, we have explored the nature of heparin binding by type I collagen monomers and fibrils. In the first series of electron microscopy experiments, heparin binding to type I procollagen was studied, as procollagen remains in the monomeric state. Since procollagen retains its COOH-terminal globular head, the polarity of the molecules can be readily identified.
Histograms of procollagen-heparin-gold mapping experiments include data from complexes that were unfixed as well as complexes fixed using three different glutaraldehyde concentrations. In all cases there was a preferred site of attachmerit of heparin-gold near the NH2-terminal end, positioned •290 nm from the head-neck juncture of the procoUagen molecule. In addition, in several preparations there was evidence of other apparently weaker sites that appear at lower concentrations of glutaraldehyde, or in the absence of fixation, at the COOH-terminal end, or at a position '~10-20 nm from the COOH-terminal end, starting from the head-neck junction. It is interesting that the COOH-terminal binding site is missing in the preparations of complexes which were fixed at high concentrations of glutaraldehyde, suggesting that glutaraldehyde treatment has eliminated that site either by amino derivitization or by modifying collagen conformation. The principle heparin-binding site on type I collagen Frozen section of nonfixed 27 rat connective tissue fibrils was found near the interface between the overlap and gap region in the vicinity of the "a " bands as shown in Fig.  6 . Experiments substantiated that this heparin-binding site occurs in this same position in reconstituted type I collagen fibrils, as well as in those of native tissue, and in fibrils from homogenized rat tail tendons. The correlation between the results from the mapping of the heparin-binding site on procoUagen with that of fibrils was facilitated using the overlap model presented by Chapman, 1974 (Fig. 5 ). In this model, the =a" bands contain elements of the NH~ terminus. Therefore, our finding that heparin attaches primarily to site(s) near the NH2 terminus of procollagen is compatible with the presence of a preferred binding site located near the division between the overlap and the gap zone in the fibrils, in the "a" bands region (see Fig. 5 ). All of the results with monomolecular complexes were obtained with type I procollagen obtained from chicken tendon fibroblasts. However, the experiments on fibrils used both native-type I collagen fibrils, and purified reconstituted native-type collagen fibrils from rat tail tendon. Given that the structural features of type I collagen are highly conserved, the comparison is most likely valid (Monson et al., 1982) .
It is important to determine the level of structural organization of the collagen fibril required for high affinity heparin binding. Previous work has shown that monomeric tropocollagen binds heparin (Obrink, 1973) , and that disrupting the triple helical conformation by melting of the collagen significantly reduces its heparin-binding affinity (Koda et al., 1985; Keller et al., 1986; San Antonio et al., 1992) . In this report we have shown that type I procollagen and fibriUar type I collagen display similar binding affinities for low molecular weight heparin. Our finding that heparin-binding sites are available for the binding of heparin-gold not only in reconstituted collagen fibrils, but also in native collagen fibrils, which are complex structures composed of types I, III, and V collagen molecules, is also considered significant. In principle, one might expect fibrillar collagen to exhibit a higher apparent affinity than procoUagen for heparin, since fibrils are potentially multivalent ligands. The fact that a higher apparent affinity was not seen suggests that any improvement in binding affinity due to multivalency is effectively offset in fibrils by a decrease in numbers of binding sites that are available. Such a decrease is expected, in fact, since a significant fraction of the collagen monomers in a fibril are thought to be buried beneath the surface, and presumably unavailable for binding.
Others have reported that when vertebrate collagenase was used to cleave type I collagen, the COOH-terminal fragment bound to a heparin affinity column more tightly than did the larger NH2-terminal fragment (Keller et al., 1986) . This is contrary to our finding of a preferred binding site near the NH2 terminus, but there are ways in which this discrepancy may be explained. For example, it is possible that a cryptic heparin-binding site in the COOH-terminal region of type I collagen is made accessible for heparin binding only after collagenase treatment. Alternatively, differences in the characteristics (e.g., size, multivalency) of the heparin-gold reagent used in the present study and the affinity matrix used by Keller et al. (1986) , may give rise to differences in accessibility of heparin-binding sites to these two reagents.
It has been proposed that heparin-binding sequences in many proteins consist of clusters of three to five basic amino acids, interspersed with hydropathic amino acids, and present within an ot helical conformation (Cardin and Weintraub, 1989) . When we searched the complete sequences of the otl and c~2 chains of human type I procollagens Tromp et al., 1988) for such consensus sequences, none were found. Thus it appears that type I collagen uses novel types of binding sites to interact with heparin and HSPGs. As an approach to identifying the heparin-binding sites on type I collagen, we examined our data showing that the primary heparin-binding site on procollagen is located near the NH~ terminus of the molecule, and that within the fibril the preferred heparin-binding site falls in the "a " bands region (see Figs. 5 c and 7). We inspected the amino acid sequences of the od and or2 chains of type I collagen in relation to the location of heparin binding we observed in the monomer and the fibril. In these regions of the collagen triple helices, we concentrated on locating amino acid sequences of net basic charge which might prove suitable as binding sites for the polyanion heparin. Interestingly, one highly basic sequence was found in the triple helix near the NH2-terminal end of procoUagen, as well as within the "a" band region of the fibril, and is present in type I collagens of human, bovine, rat, and chick Hulmes et al., 1973; Tromp et al., 1988) (Fig. 7) . This locus consists of nine basic amino acids, six of them contributed by the otl chains, and three by the o~2 chain, as shown below:
cd: hlys-gly-his-arg-gly-phe c~2: hlys-gly-ile-arg-gly-his
In the cd chain of rat tropocollagen, this site includes amino acid residues 87-92 (Hulmes et al., 1973) . Three of the basic amino acids within this sequence are hydroxylysine residues, which are involved in cross-links, and which sometimes function as dissacharide acceptor sites (Buffer and Cunningham, 1965, 1966) . We propose that this domain may function as a heparin-binding site in type I collagen. It should be stressed that there are other clusters of basic amino acids located in the collagen triple helices constituting the "a" band fibril region, but these all include fewer basic amino acids than the site discussed above, and often are present in close proximity to triple helical domains carrying strong negative charges (Fig. 7) .
In the type I collagen monomer one other highly basic domain exists in the triple helix near the carboxy terminus (Fig.   7, arrow 7) , and it also contains hydroxylysine residues involved in cross-links (Butler and Cunningham, 1966) . The domain carries eight positive charges, and differs from the primary sequences of our proposed heparin-binding site, in both the composition and arrangement of some of its positively charged amino acids. It is possible that the weak heparin binding we observed near the COOH-terminal end of procollagen (Fig. 4 , b and c) may be partially or wholly due to heparin binding to the COOH-terminal basic domain described above. In fact, this same site could be responsible for the heparin-binding affinity attributed to the COOH-terminal portion of type I collagen (Keller et al., 1986) . The potential error in positioning the heparin-gold reagent relative to procollagen, however, makes it difficult at present to distinguish between binding of heparin-gold to the putative COOHterminal heparin-b'mding sequence, as opposed to other basic domains near or on the globular head of procollagen.
It has been predicted that the proteoglycan-binding site should be in the "a" and "c2" band regions of the type I collagen fibril (see Figs. 5 c and 7), based on fibril staining patterns, as well as the concentration of unpaired positive charges of the combined rat and bovine sequences of the t~l chains (Doyle et al., 1975) . It is significant in the present study that we observed heparin binding mainly to the "a" bands of native type I collagen. Previous work showed, however, that in tissues the location of various types of proteoglycans (e.g., dermatan and keratan sulfate PGs) on type I collagen fibrils is not limited to the "a" bands region, but can also occur within the "c, "d" or "e" bands regions (see Figs. 5 c and 7) of the 67-nm period (for review see Ruoslahti, 1988; Scott, 1988 Scott, , 1991 . Further work is necessary to determine if in vivo cell surface or extracellular matrix forms of HSPGs preferentially occupy the "a" bands region of type I collagen fibrils.
The relationships between the cell-attachment sites of type I collagen fibrils and heparin-binding sites are of great interest because heparin and syndecan-1 block cell adhesion to type I collagen in vitro (Koda et al., 1985; Piepkorn and Chapman, 1985) . It is proposed that proteoglycans have this effect because they bind extracellular matrix molecules at sites that are adjacent to cell-attachment sites and thereby sterically hinder the binding of cell surface integrin receptors (Brennan et al., 1983) .
The spatial relationship between the putative heparinbinding site and various potential cell-attachment sites on collagen fibrils are considered in Fig. 7 . An average heparin molecule of 15,000 D is ~30-nm long. If collagen-binding sites on heparin consist of randomly distributed pentasaccharide sequences (as do antithrombin HI-binding sites [Marcum and Rosenberg, 1989] ), then a locus on heparin of ,x,2.5 nm could span the putative heparin-binding site on the collagen triple helix. In the collagen fibril, tropocollagen molecules are *300-nm long, the intermolecular spacing between them is ',,1.5 nm, and the length of one fibril repeat unit is ,~67 nm (Brodsky and Eikenberry, 1982) . Thus, heparin molecules would not be long enough to span the distance between two heparin-binding sites of adjacent 67-am periods (see Figs. 5 and 7) . Heparin molecules would, however, be long enough to bind to a heparin-binding site on one tropocollagen helix, and span the distance between this site, and certain cell-attachment domains on adjacent tropocollagen monomers (e.g., Chapman (1974) for the overlap of the eel chains of rat type I collagen within the fibril was used as a guide to align the t~l chains of the human molecule, based on the high degree of sequence homology between the collagens of these species. The distribution of charged residues of the human protein matched nearly exactly with those of the rat, although it was necessary to delete several nonhomologous residues from the human sequence to achieve alignment. The fibril portion shown is an expanded diagram of the molecules within the boxed area of Fig.  5 b, and includes one overlap and one gap zone, as indicated. Horizontal bars represent segments of five overlapping triple helical tropocollagen molecules, with the NH2 terminus (N) of one monomer located at the upper left of the diagram, and the COOH terminus (C) of another monomer at the lower right of the diagram; spacing between tropocollagen molecules is not to scale. Vertical bars represent total charge density at each residue unit along each triple helix, i.e., these values were determined by aligning the primary sequences of the human type I collagen t~l and u2 chains Tromp et al., 1988) , and summing the charges of the three aligned residues across the chains of the triple helix. The location of the proposed heparin-binding domain is indicated (black arrow). Potential cell attachment sites and RGD sequences include DGEA (arrow 1 ) (Staatz et al., 1990 (Staatz et al., , 1991 oftbe cd chains of human, chicken, bovine, and rat; RGDA of the cd chains of the human (arrow 2); RGDT of the ct2 chain of the chicken but not human protein (arrow 3) (Dedhar et al., 1987; Pignatelli and Bodmer, 1988) ; RGDG of the a2 chain of the human (arrow 4); RGDQ of the c~2 chain of the human (arrow 5); and RGDK of the od and ct2 chains of the human (arrow 6) (see Hulmes et al., 1973; Bernard et al., 1983; Kuivaniemi et al., 1988; Tromp et al., 1988 for all sequences). Basic domain near COOH terminus showing sequence homology to proposed heparin-binding site (see Discussion) is indicated (arrow 7). Letters and bars at bottom of figure   3 ), thereby potentially influencing cell-collagen interactions. The precise in vivo role of HSPGs as regulators of integrin receptor-collagen interactions will remain uncertain, however, until the locations of available integrinbinding sites on native type I collagen fibrils have been mapped. It is of interest to speculate on the in vivo role of the heparin-binding site of type I collagen. Possibly, this site functions to join extracellular matrix PGs and collagen fibrils, to give structural support to certain connective tissues, or to control aspects of collagen fibriUogenesis (e.g., see Ruoslahti and Engvall, 1980; Vogel et al., 1984; Ruoslahti and Pierschbacher, 1987; Scott and Parry, 1992) . Alternatively, the heparin-binding site of type I collagen may function in cell adhesion, as a primary matrix receptor for cell surface HSPGs (Koda et al., 1985; Sanderson et al., 1992) . For example, via this binding site, cell surface HSPGs may act as coreceptors, by bringing extraceUular ligands (e.g., collagen) together with high affinity cell surface receptors for these ligands (e.g., integrins) (see Bernfield et al., 1992 for review). Thus, given the abundance of HSPGs and type I collagen fibrils in most tissues, it is likely that the heparinbinding site on type I collagen participates in key physiological processes such as cell adhesion, migration, or celldirected assembly or restructuring of the extracellular matrix.
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